Thyrocare Technologies Stock Soars to All-Time High, Signaling Market Dominance

Thyrocare Technologies has reached an all-time high, marking a significant milestone for the small-cap healthcare services company. On November 13, 2025, the stock price touched Rs 1463, reflecting a robust performance that has outpaced its sector by 4.37%. Over the past three days, Thyrocare has demonstrated a strong upward trend, gaining 7.63% in returns.
The company has consistently shown impressive financial metrics, including a remarkable 59.92% increase in net profit over the past year and a high return on equity (ROE) of 23.66%. Thyrocare's net sales for the latest quarter reached Rs 216.53 crore, the highest recorded, while its profit before tax (PBT) grew by 74.22%.

In terms of market performance, Thyrocare has outperformed the BSE500 index over various time frames, including a 127.05% increase over the past three years. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong bullish trend. This achievement underscores Thyrocare Technologies' solid market position and operational efficiency in the healthcare sector.